Six things to know: How health execs might benefit from Trump’s plans
Free market principles and increased competition among payers, combined with potential quality-related incentives, may hasten the speed at which providers focus on quality-improvement initiatives. “Competition usually leads to benefits such as decreased costs and improved quality,” Denton says. “Broadening the playing field to include a larger number of contributing thought leaders and looking to proven experiences and lessons learned, along with the hope of market share gains and increased profits, could yield overall benefits for patients—especially in terms of quality of care.”
Various quality-related measures are already in place, including The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and the most recent iteration of CMS’ star ratings. “Given their broad bipartisan support, it is expected that Trump will continue these initiatives,” Denton says.